AYUSH Ministry issues revised advisory to fight against COVID-19

Published On 2022-01-14 03:45 GMT   |   Update On 2022-01-14 03:45 GMT
Click the Play button to listen to article

New Delhi: As India witnesses a steep surge in COVID-19 cases, the Ministry of AYUSH (MoA) on Wednesday issued revised guidelines and advisory to fight against coronavirus infection. In the advisory, MoA said, "People should use Ayuraksha kit which has chyawanprash, 6pgm once a day, Ayush Kwath 75ml once a day, Samshamani Vati 500 mg twice a day, Anutaila one to two drops nasal application...

Login or Register to read the full article

New Delhi: As India witnesses a steep surge in COVID-19 cases, the Ministry of AYUSH (MoA) on Wednesday issued revised guidelines and advisory to fight against coronavirus infection.

In the advisory, MoA said, "People should use Ayuraksha kit which has chyawanprash, 6pgm once a day, Ayush Kwath 75ml once a day, Samshamani Vati 500 mg twice a day, Anutaila one to two drops nasal application in each nostril once a day."

Also Read:Union Health Ministry updates home isolation rules: Quarantine period cut to 7 days

The ministry also recommends a few medicines against coronavirus infection. "AYUSH-64 (2 tablets of 500 mg twice in a day in asymptomatic COVID-19, 2 tablets of 500 mg thrice a day in mild to moderate COVID), Kabasura Kudineer (5 gm twice in a day)," the ministry said.

For COVID-19 Prophylaxis, it recommends Arsenicum album 30C, Khareema Marwareed medicines.

This came after the Union Health ministry addressed a press conference on the COVID-19 management in the national capital today.

Also Read:Now Ayurvedic practitioners can issue medical certificate for driving license

Tags:    
Article Source : ANI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News